Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014	Mar. 31, 2013
Income Statement [Abstract]
REVENUES:				$ 10,361
OPERATING EXPENSES:
Research and development	2,151,225	2,944,587	8,230,733	7,733,670
General and administrative	1,212,513	1,079,197	3,236,093	3,141,751
Total operating expenses	3,363,738	4,023,784	11,466,826	10,875,421
Loss from operations	(3,363,738)	(4,023,784)	(11,466,826)	(10,865,060)
OTHER INCOME (EXPENSE):
Investment income	4,363	9,629	14,613	37,017
Interest expense	(182)	(1,103)	(2,987)	(4,746)
Increase in fair value of warrants				(7,069,165)
Gain on disposition of supplies and equipment				4,620
Total other income (expense), net	4,181	8,526	11,626	(7,032,274)
Loss before income taxes	(3,359,557)	(4,015,258)	(11,455,200)	(17,897,334)
Income tax benefit	1,846,646		1,846,646	1,753,208
NET LOSS	$ (1,512,911)	$ (4,015,258)	$ (9,608,554)	$ (16,144,126)
Basic and diluted net loss per common share	$ (0.01)	$ (0.04)	$ (0.09)	$ (0.17)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	106,709,340	106,424,443	106,668,094	94,754,789